期刊
STROKE
卷 37, 期 9, 页码 2368-2371出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.STR.0000236496.30106.4b
关键词
acute stroke; insulin-like growth factor 1; neuroprotection; thrombolysis; tissue plasminogen activator
Background and Purpose-Insulin-like growth factor (IGF)-1 has potent neuroprotective properties. We investigated the effects of intravenous administration of tissue plasminogen activator (tPA) on serum levels of IGF-1 and IGF-binding protein (IGFBP)-3 in patients with acute ischemic stroke. Methods-Serum levels of total IGF-1, free IGF-1, and IGFBP-3 were measured by radioimmunoassay in 10 patients with ischemic stroke treated with intravenous tPA (0.9 mg/kg body weight) and 10 untreated controls. Results-During tPA treatment, total IGF-1 and IGFBP-3 serum levels did not change, but there was an approximate to 70% increase in free IGF-1 serum levels from 0.98 +/- 0.25 at baseline to 1.69 +/- 0.18 nmol/L at the end of the I-hour infusion (P=0.01). Conclusions-Intravenous therapy with tPA enhances the bioavailability of IGF-1. Conclusions-Intravenous therapy with tPA enhances the bioavailability of IGF-1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据